Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore
Remidex manufactures micronutrient premixes and nutraceuticals,
Remidex manufactures micronutrient premixes and nutraceuticals,
The new equipment will be installed at Codis’ 400,000-square-foot Haverhill facility and is expected to be operational by 2027
The first of four planned modules at the new plant is expected to come online by summer 2026
ShunzymeX leverages a proprietary protease to streamline purification
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
The facility is expected to become operational by FY2028-29
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
Subscribe To Our Newsletter & Stay Updated